A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if using Eprex, to maintain hemoglobin within the
normal range, will prevent or delay the progression of left ventricular mass growth.